Patents
Patents for C07D 281 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms (1,924)
12/2007
12/25/2007US7312208 Quaternary ammonium compounds
12/19/2007EP1347967B1 Novel benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists
12/19/2007CN101090894A Macrocyclic compounds and compositions useful as BACE inhibitors
12/12/2007EP1863776A1 N-hydroxyamides omega-substituted with tricyclic groups as histone deacetylase inhibitors, their preparation and use in pharmaceutical formulations
12/12/2007CN100354281C Process for preparation of 9-amino substituted 9,10-dihydropyrrolo [2,1-b] [1,3] benzotiazepines
12/06/2007WO2006056772A3 Salts of quetiapine
12/05/2007EP1861385A1 Novel anti-arrythmic and heart failure drugs that target the leak in the ryanodine receptor (ryr2)
12/04/2007US7304047 Method of treating substance abuse with quetiapine
11/2007
11/22/2007WO2007062336A3 Salt forms
11/22/2007US20070270402 (+) or (-)-9-(piperazin-1-yl)-9,10-dihydropyrrolo[2,1-b][1,3]benzothiazepine; schizophrenia, paranoid states, manic-depressive states, social regression, personality regression, hallucination, appetite disorders
11/21/2007EP1856073A1 A PROCESS FOR THE PREPARATION OF AN 11-(4-SUBSTITUTED-I-PIPERAZINYL)DIBENZO[b,f][1,4]THIAZEPINE DERIVATIVE
11/15/2007WO2007062338A3 Solid formulations
11/14/2007EP1853569A1 Ligands for g-protein coupled receptors
11/13/2007US7294622 Lactams and uses thereof
10/2007
10/25/2007US20070249582 Method of Treating Substance Abuse with Quetiapine
10/24/2007EP1846382A2 Controlled release compositions comprising an antipsychotic agent
10/18/2007WO2007117180A1 Azaheterocycles, combinatory library, focused library, pharmaceutical composition and methods for the production thereof
10/17/2007EP1845089A1 Novel lactams and uses thereof
10/11/2007WO2007008226A3 Palladium-catalyzed carbon-carbon bond forming reactions
10/10/2007EP1841751A1 INDUSTRIAL PREPARATION OF 11-(4-(2-(2-HYDROXYETHOXY ETHYL)-1-PIPERAZINYL)DIBENZO (b,f)-1(1, 4)THIAZEPINE
10/09/2007US7279582 For example (2S, 3S, 5S)-2-(2,6-dimethylphenoxyacetyl)amino-3-hydroxy-5-(2S-(1-tetrahydro-pyrimid-2-onyl)-3-methyl butanoyl)amino-1,6-diphenylhexane; HIV therapy
10/09/2007US7279573 Benzodiazepine derivatives that may be fused to a pyrroline or piperidine ring; e.g., N-[1 (R)-(3-Aminopropylcarbamoyl)-2-(naphthalen-2-yl)ethyl]-3-(5,11-dioxo-2,3-dihydro-1H-(11aS)-pyrrolo[2,1-c][1,4]benzodiazepin-10-yl)propionamide; increasing levels of endogenous growth hormones in humans and animals
10/04/2007WO2007111026A1 Optical film
10/03/2007EP1838680A2 Macrocyclic compounds and compositions useful as bace inhibitors
09/2007
09/27/2007US20070225494 Process for the Preparation of 11-(4-[2-(2-Hydroxyethoxy)Ethyl]-I-Piperazinyl)Dibenzo[b,f][I,4]Thiazepine
09/26/2007EP1554250B1 Novel lactams and uses thereof
09/20/2007WO2007104933A1 Chemical compounds
09/20/2007US20070219180 Muscle Relaxtion Accelerator and Therapeutic Agent for Muscular Tissue Diseases Such as Muscle Relaxation Failure
09/13/2007WO2007101347A1 Bir domain binding compounds
09/13/2007US20070213364 Alkoxyphenylpropanoic Acid Derivatives
09/13/2007CA2642659A1 Process for preparing dibenzothiazepine compounds
08/2007
08/30/2007US20070203336 Process for preparing dibenzothiazepine compounds
08/30/2007US20070203115 Novel quaternary ammonium compounds
08/29/2007EP1660469B1 Process for the preparation of 11-(1-piperazinyl)dibenzo 'b, f! '1 ,4!-thiazepine, an intermediate in the synthesis of the antipsychotic drug quetiapine
08/22/2007EP1819679A2 2-alcoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof
08/16/2007US20070190041 Novel benzothiazepine and bensothiepine compounds
08/01/2007EP1294698B1 Fused azepine derivatives and their use as antidiuretic agents
07/2007
07/18/2007EP1660468B1 Procedure for preparing 11-(4-[2-(2-hydroxyethoxy)ethyl]-1-piperazinyl)-dibenzo[b,f][1,4]thiazepine
07/12/2007US20070160537 In vivo screening method of therapeutic agent for memory/learning dysfunctions by schizophrenia
07/03/2007US7238686 stable, reproducible two crystalline forms; prepared by dissolving quetiapine free base and fumaric acid in suitable solvent and crystallizing fumarate salt; suitable solvents are ketones like acetone, methyl iso butyl ketone; esters like ethyl acetate, ethyl formate, methyl acetate; and mixture
06/2007
06/13/2007EP1795199A2 Quetiapine for the treatment of substance dependence or substance abuse
06/13/2007EP1794137A2 Specific kinase inhibitors
06/12/2007US7229984 Dibenzoxazepinone derivatives and uses thereof
06/12/2007US7229983 antibacterial; beta -lactam antibiotics
06/05/2007USRE39679 Substituted heterocycle fused gamma-carbolines
05/2007
05/24/2007US20070117787 N-[(3R,5S)-1-(3-Acetoxy-2,2-dimethylpropyl)-7-chloro-5-(2,3-dimethoxyphenyl)-2-oxo-1,2,3,5-tetrahydro-4,1-benzoxazepine-3-acetyl]piperidine-4-acetic acid; in combination with a statin, lowering cholesterol-level and lowering triglyceride-level
05/17/2007US20070111987 cyclization using phosphorus oxychloride; antipsychotic or neuroleptic agent for psychological disorders
05/17/2007US20070111986 comprises the ring closure and deprotection of an intermediate; 11-(4-[2-(2-hydroxyethoxy)ethyl]-1-piperazinyl]dibenzo[b,f]-1,4-thiazepine; used as an antipsychotic or neuroleptic
05/09/2007EP1781646A1 Process for the preparation of 11-(4-[2-(2-hydroxyethoxy)ethyl]-i-piperazinyl)dibenzo[b,f][1,4]thiazepine
05/08/2007US7214793 Reacting dithiodisalicylic acid with 1-chloro-2-nitrobenzene in a basic aqueous solution; reducing the nitro group of the 2-(2-nitrophenylthio)benzoic acid formed with hydrogen gas, a solvent and a heterogeneous metal catalyst; and cyclizing the product in an organic solvent
05/08/2007CA2342950C New process for preparing 11-amino-3-chloro-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo[c,f][1,2]-thia zepine and application in the synthesis of tianeptine
05/03/2007WO2007049532A1 Aminodihydrothiazine derivative
05/03/2007WO2007048870A1 Quetiapine hemifumarate purification by crystallization
05/03/2007US20070099848 Rapamycin carbohydrate derivatives
05/03/2007CA2628074A1 Aminodihydrothiazine derivative
04/2007
04/26/2007WO2007047737A1 Cb-1 modulating compounds and their use
04/26/2007CA2625423A1 Cb-1 modulating compounds and their use
04/25/2007EP1776160A1 Novel serotonin receptor ligands and their uses thereof
04/25/2007EP1359919B1 Use of quetiapine for the treatment of cocaine dependence
04/19/2007WO2007009656A3 Novel 1,4-benzothiazepine-1,1-dioxide derivative having improved properties, method for the production thereof, medicaments containing said compound, and use thereof
04/19/2007US20070088020 Agonists to a cannabinoid type 2 receptor; antiinflammatory agents; immunosuppressants; nephritis
04/18/2007EP1345918B1 1,5 benzothiazepines and their use as antihyperlipidemics
04/17/2007US7205334 vacuolar-type (H+)-ATPase-inhibiting macrocyclic lactams belonging to the chondropsin class useful in cancer chemotherapy
04/17/2007CA2295792C A crystalline dibenzothiazepine derivative and its use as an antipsychotic agent
04/10/2007US7202256 Proline CCI-779, production of and uses therefor, and two-step enzymatic synthesis of proline CCI-779 and CCI-779
04/05/2007WO2007036599A1 New crystallization process of quetiapine hemifumarate
04/04/2007CN1308313C Fused azepine drivatives and their use as antidiuretic agents
03/2007
03/29/2007US20070072792 Macrocyclic lactams and pharmaceutical use thereof
03/22/2007US20070066589 Method of preparing 10th-dibenzo[b,f][11,4]thiazepin-11-one
03/20/2007US7192950 Psychological disorders; eating disorders; dietetics
03/20/2007US7192948 Bicyclic heterocycles as HIV integrase inhibitors
03/20/2007US7192947 Peptides derivatives comprising thiazepine group for the treatment of hyperlipidemic conditions
03/20/2007US7192946 Hyperlipemia agents; bile acid transport inhibitors
03/20/2007US7192945 Benzothiazepine derivatives
03/13/2007CA2264063C Cryptophycin compounds
03/07/2007CN1923794A Process for production of high-purity enamines
03/01/2007WO2006117700A3 Process for preparing quetiapine and quetiapine fumarate
03/01/2007WO2005030711A3 Bridged macrocyclic module compositions
02/2007
02/22/2007WO2007020011A1 Processes for the preparation of thiazepines
02/22/2007WO2006081347B1 Controlled release compositions comprising an antipsychotic agent
02/14/2007EP1751168A1 Proline cci-779 (proline-rapamycin 42-ester with 2,2-bis (hydroxymethyl) propionic acid) and two-step enzymatic synthesis of proline cci-779 and cci-779 using microbial lipase
02/14/2007CN1914214A Tricycle indole hydroxyethlamine derivatives and their use in the treatment of alzheimer's disease
02/13/2007US7176195 Treatment of nocturnal enuresis, nocturia, polyuria resulting from central diabetes insipidus, urinary incontinence or bleeding disorders such a hemophilia
02/07/2007CN1907977A Process for preparing diltiazem intermediate
02/01/2007WO2006049734A3 Quetiapine analogs and methods of use thereof
01/2007
01/25/2007WO2007009655A1 1,4-benzothiazepine 1,1-dioxide derivative, process for its preparation, medicaments comprising this compound, and use thereof as a hypolipidaemic
01/25/2007DE102005033100B3 Neues 1,4-Benzothiazepin-1,1-Dioxidderivat mit verbesserten Eigenschaften, diese Verbindung enthaltene Arzneimittel und Verfahren zu deren Herstellung New 1,4-benzothiazepine-1,1-Dioxidderivat with improved properties, these drug compound contained and processes for their preparation
01/25/2007CA2614697A1 Novel 1,4-benzothiazepine-1,1-dioxide derivative having improved properties, method for the production thereof, medicaments containing said compound, and use thereof
01/25/2007CA2614524A1 1,4-benzothiazepine 1,1-dioxide derivative, process for its preparation, medicaments comprising this compound, and use thereof as a hypolipidaemic
01/24/2007CN1902182A Macrocyclic lactams and pharmaceutical use thereof
01/17/2007EP1743895A1 Muscle relaxation accelerator and therapeutic agent for muscular tissue diseases such as muscle relaxation failure
01/17/2007EP1742707A2 Treatment of cns disorders using cns target modulators
01/11/2007WO2007004234A1 A PROCESS FOR THE PREPARATION OF 2-[2-(4-DIBENZO[b,f] [L,4] THIAZEPIN-11-yl-1- PIPERAZINYL)ETHOXY] ETHANOL FUMARATE
01/09/2007CA2394720C Cyanomethylene compounds and fungicidal compositions
12/2006
12/28/2006WO2006081347A3 Controlled release compositions comprising an antipsychotic agent
12/27/2006EP1427423B1 Benzothiazepine and benzothiadiazepine derivatives with ileal bile acid transport (ibat) inhibitory activity for the treatment hyperlipidaemia
12/21/2006WO2006135544A1 SYNTHESIS OF 11-(4[-(2-HYDROXYETHOXY)ETHYL]-PIPERAZINYL)-DIBENZO[b,f][1,4]THIAZEPINE AND ITS FUMARATE SALT
12/13/2006EP1731505A1 Alkoxyphenylpropanoic acid derivatives
12/06/2006EP1345610B1 Quetiapine for treating of dyskinesia in non-psychotic patients
12/06/2006CN1872846A Method of preparing 2-benzothiazepines derivative
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 ... 20